Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 AUD | -2.39% | +4.05% | +12.68% |
26/02 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
25/02 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Sales 2024 * | 384M 251M 20.93B | Sales 2025 * | 429M 281M 23.39B | Capitalization | 562M 367M 30.63B |
---|---|---|---|---|---|
Net income 2024 * | -83M -54.22M -4.52B | Net income 2025 * | -2M -1.31M -109M | EV / Sales 2024 * | 1.28 x |
Net cash position 2024 * | 72.1M 47.09M 3.93B | Net cash position 2025 * | 60.91M 39.79M 3.32B | EV / Sales 2025 * | 1.17 x |
P/E ratio 2024 * |
-6.77
x | P/E ratio 2025 * |
-202
x | Employees | 967 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.67% |
Latest transcript on Mayne Pharma Group Limited
1 day | -2.39% | ||
1 week | +4.05% | ||
Current month | -4.28% | ||
1 month | +1.17% | ||
3 months | +29.53% | ||
6 months | +80.94% | ||
Current year | +12.68% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn O'Brien
CEO | Chief Executive Officer | - | 01/22/01 |
Aaron Gray
DFI | Director of Finance/CFO | - | 29/22/29 |
Keith Moore
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Condella
CHM | Chairman | 70 | 30/18/30 |
Patrick Blake
BRD | Director/Board Member | 59 | 28/18/28 |
Shawn O'Brien
CEO | Chief Executive Officer | - | 01/22/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 6.93 | -2.39% | 63,848 |
24/24/24 | 7.1 | -0.28% | 73,461 |
23/24/23 | 7.12 | +4.25% | 197,322 |
22/24/22 | 6.83 | +2.55% | 246,992 |
19/24/19 | 6.66 | -1.33% | 130,562 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 367M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- MYX Stock